These observations, when considered in combination with the elevation of angiotensin II receptor in rats with an altered AHR transactivation domain, suggests that one physiologic function of the AHR is to suppress activity of the angiotensin II system and reduce the potential for hypertension and subsequent cardiac hypertrophy and fibrosis [46]. This evidence concerns the gene AHR and cardiac hypertrophy.